By Jonathan Cable and Rahul Karunakar LONDON/BENGALURU - The blistering rally in global stock markets is set to continue for at least six months, albeit at a shallower pace, amid hopes more cheap cash and a COVID-19 vaccine allow economies to heal and corporate earnings to recover, a Reuters poll found. With the coronavirus pandemic sweeping across the globe, economic activity ground

Economy

Vaccines

Coronavirus

Reuters

News18 India

Global stocks bull run to race on, spurred by cheap cash, vaccine hopes - Reuters poll

PARIS - French Industry Minister Agnes Pannier-Runacher said on Wednesday that Sweden-based pharmaceutical company Recipharm has signed a letter of intent with U.S. firm Moderna to produce some of its COVID-19 vaccine candidate in France. Pannier-Runacher said that Recipharm has four plants in France. The head of the European Commission said on Tuesday that the European Union has

International

Today

France welcomes Recipharm and Moderna agreement over COVID vaccine

Sinopharm official says approval top priority before marketization - Anadolu Agency

Business

Finance

Asia

The Nation 

Anadolu Ajansı

Bloomberg Quint

China company seeks approval for COVID-19 vaccine

Using blood plasma from COVID-19 survivors to treat patients with severe pneumonia caused by the novel coronavirus showed little benefit, according to data released on Tuesday from a clinical trial in Argentina. The therapy know as convalescent plasma, which delivers antibodies from COVID-19 survivors to infected people, did not significantly improve patients'

Health

Science

New York, NY

New York

Yahoo News

The Star Kuala Lumpur

WION

Science Media Centre

Plasma from recovered patients shows little benefit in those hospitalized with COVID-19

The European Union (EU) will give the green light to a new vaccine contract in its bid to fight the COVID-19 pandemic, said European Commission President Ursula von der Leyen on Tuesday.

Ursula von der Leyen

European Union

European Commission

Pandemic

Bangkok Post 

Ecns

People's Daily

EU to approve new COVID-19 vaccine contract

As expectations grow that the first Covid-19 jabs will be administered in a matter of weeks, German glassmaker Schott is quietly doing what it has been for months: churning out vials that will hold the vaccine.
The 130-year-old company, whose founder Otto Schott invented the high-quality borosilicate glass favoured by the pharma industry, has been working round the clock to meet unprecedented demand.

Europe

Oceania

Berlin, Germany

Berlin

IBTimes

IBTimes Australia

German Vials In Spotlight As Covid-19 Vaccine Nears

By Katanga Johnson WASHINGTON - Asian stocks made early gains on Wednesday, following a world rally overnight that saw the Dow Jones benchmark crack 30,000 for the first time as investors cheered a dramatically improved global outlook. The main drivers of that exuberance were increasing confidence a COVID-19 vaccine would be ready soon and the formal start of U.S. president-elect Joe

Wall Street

Middle East

Americas

Stock markets

Tokyo, Japan

Times of India

Channel News Asia

Stocks rise as vaccines, Biden presidency lift global confidence

The state vaccine committee will hold a meeting with Bharat Biotech representatives on Wednesday to discuss the study design, said a committee member.

Indian Express

Gujarat: Bharat Biotech Covid vaccine reaches Sola hospital for trial

A coronavirus vaccine will begin to become available in the United States "probably by the end of the second week in December," Centers for Disease Control and Prevention Director Dr. Robert Redfield told Fox News Tuesday.



Vaccinations

Politics

North America

Medical

Videos

Washington DC

Washington

The Hill

Washington Examiner

Newsmax

National Review

The Daily Wire

Redfield projects COVID-19 vaccine to be rolled out by 'end of the second week in December'

Anthony Fauci, the nation’s top infectious diseases expert, on Monday said he's "concerned" about the stalled transition process between President Trump and President-elect Joe Biden.



Vaccines

Stay current with the most up to date news on Vaccines with news from hundreds of news sources

Trending Stories

Vaccines Blindspots

FOR THE LEFT

FOR THE RIGHT

Vaccines News

Trending topics

Blindspot report

Burst your Bubble report

Explore more topics